Medical Blog About Treatment Abroad

Anal carcinoma is a rare but increasingly common, malignant neoplasm: the incidence has increased by approximately 2.7% per year over the past decade. Squamous cell carcinoma (SCC) accounts for approximately 85% of all cases. Although anal carcinoma is relatively rare compared with other malignancies, it has a notable...

Thyroid cancer (TC) remains the most common endocrinological cancer worldwide, with a disturbingly increasing incidence rate over recent years. The reason for this is not only a greater awareness of this malignancy and in-depth diagnosis leading to the early detection of less typical clinical symptoms but also its increasing...

Osteosarcoma (OS) or osteogenic sarcoma is a relatively rare but aggressive primary malignant bone tumour. It makes up about 20% of all malignant bone tumors and mostly affects kids and teenagers before age 25. Active bone tissue growth gives young people more chances to get this type of cancer. The risk factors of osteosarcoma also...

Breast cancer is the most common malignant disease among women in Europe. It is a heterogeneous disease, the pathogenesis of which remains unclear in most cases. Significant progress has been made in early diagnosis and treatment of breast cancer, which has led to improved survival rates. Different molecular subtypes of breast...

Dendritic cell-based immunotherapy is the administration of individually manufactured vaccines based on the genetic characteristics of a tumor in a particular person. Cancer treatment with dendritic cells is indicated even for those patients who have not responded to all other types of therapy. In Europe, vaccination is possible in any stage...

The regional chemotherapy (RCT) approach is an oncological approach with a very low toxicity profile and high tumor response due to high cytotoxic drug concentrations in an isolated perfusion bed. In addition, the therapy can be focused on limited regions if necessary, using the same technique (e.g., upper abdominal perfusion...

In 2020 over 573,000 new bladder cancer (BC) cases and around 212,000 BC deaths were estimated to occur worldwide, representing approximately 3% of all new cancer cases and more than 2% of cancer deaths. BC ranks as the tenth most common cancer diagnosed and the 13th most common cause of cancer mortality worldwide.

In the whole world, the German health care system is recognized as one of the best and most advanced systems. This is because it consistently delivers impressive patient outcomes. Worldometers shows that the average life expectancy in Germany is around 81.7 years. This data allows placing the country among the global leaders in...